FDA orders boxed warning for Regranex
Monday, June 9, 2008 - 12:49
in Health & Medicine
WASHINGTON, June 9 (UPI) -- The U.S. Food and Drug Administration announced the addition of a boxed warning for Regranex (becaplermin) because of an increased risk of cancer mortality.